Cargando…

TMEM16F/Anoctamin 6 in Ferroptotic Cell Death

Ca(2+) activated Cl(−) channels (TMEM16A; ANO1) support cell proliferation and cancer growth. Expression of TMEM16A is strongly enhanced in different types of malignomas. In contrast, TMEM16F (ANO6) operates as a Ca(2+) activated chloride/nonselective ion channel and scrambles membrane phospholipids...

Descripción completa

Detalles Bibliográficos
Autores principales: Ousingsawat, Jiraporn, Schreiber, Rainer, Kunzelmann, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562394/
https://www.ncbi.nlm.nih.gov/pubmed/31060306
http://dx.doi.org/10.3390/cancers11050625
_version_ 1783426289739235328
author Ousingsawat, Jiraporn
Schreiber, Rainer
Kunzelmann, Karl
author_facet Ousingsawat, Jiraporn
Schreiber, Rainer
Kunzelmann, Karl
author_sort Ousingsawat, Jiraporn
collection PubMed
description Ca(2+) activated Cl(−) channels (TMEM16A; ANO1) support cell proliferation and cancer growth. Expression of TMEM16A is strongly enhanced in different types of malignomas. In contrast, TMEM16F (ANO6) operates as a Ca(2+) activated chloride/nonselective ion channel and scrambles membrane phospholipids to expose phosphatidylserine at the cell surface. Both phospholipid scrambling and cell swelling induced through activation of nonselective ion currents appear to destabilize the plasma membrane thereby causing cell death. There is growing evidence that activation of TMEM16F contributes to various forms of regulated cell death. In the present study, we demonstrate that ferroptotic cell death, occurring during peroxidation of plasma membrane phospholipids activates TMEM16F. Ferroptosis was induced by erastin, an inhibitor of the cystine-glutamate antiporter and RSL3, an inhibitor of glutathione peroxidase 4 (GPX4). Cell death was largely reduced in the intestinal epithelium, and in peritoneal macrophages isolated from mice with tissue-specific knockout of TMEM16F. We show that TMEM16F is activated during erastin and RSL3-induced ferroptosis. In contrast, inhibition of ferroptosis by ferrostatin-1 and by inhibitors of TMEM16F block TMEM16F currents and inhibit cell death. We conclude that activation of TMEM16F is a crucial component during ferroptotic cell death, a finding that may be useful to induce cell death in cancer cells.
format Online
Article
Text
id pubmed-6562394
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65623942019-06-17 TMEM16F/Anoctamin 6 in Ferroptotic Cell Death Ousingsawat, Jiraporn Schreiber, Rainer Kunzelmann, Karl Cancers (Basel) Article Ca(2+) activated Cl(−) channels (TMEM16A; ANO1) support cell proliferation and cancer growth. Expression of TMEM16A is strongly enhanced in different types of malignomas. In contrast, TMEM16F (ANO6) operates as a Ca(2+) activated chloride/nonselective ion channel and scrambles membrane phospholipids to expose phosphatidylserine at the cell surface. Both phospholipid scrambling and cell swelling induced through activation of nonselective ion currents appear to destabilize the plasma membrane thereby causing cell death. There is growing evidence that activation of TMEM16F contributes to various forms of regulated cell death. In the present study, we demonstrate that ferroptotic cell death, occurring during peroxidation of plasma membrane phospholipids activates TMEM16F. Ferroptosis was induced by erastin, an inhibitor of the cystine-glutamate antiporter and RSL3, an inhibitor of glutathione peroxidase 4 (GPX4). Cell death was largely reduced in the intestinal epithelium, and in peritoneal macrophages isolated from mice with tissue-specific knockout of TMEM16F. We show that TMEM16F is activated during erastin and RSL3-induced ferroptosis. In contrast, inhibition of ferroptosis by ferrostatin-1 and by inhibitors of TMEM16F block TMEM16F currents and inhibit cell death. We conclude that activation of TMEM16F is a crucial component during ferroptotic cell death, a finding that may be useful to induce cell death in cancer cells. MDPI 2019-05-05 /pmc/articles/PMC6562394/ /pubmed/31060306 http://dx.doi.org/10.3390/cancers11050625 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ousingsawat, Jiraporn
Schreiber, Rainer
Kunzelmann, Karl
TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
title TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
title_full TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
title_fullStr TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
title_full_unstemmed TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
title_short TMEM16F/Anoctamin 6 in Ferroptotic Cell Death
title_sort tmem16f/anoctamin 6 in ferroptotic cell death
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562394/
https://www.ncbi.nlm.nih.gov/pubmed/31060306
http://dx.doi.org/10.3390/cancers11050625
work_keys_str_mv AT ousingsawatjiraporn tmem16fanoctamin6inferroptoticcelldeath
AT schreiberrainer tmem16fanoctamin6inferroptoticcelldeath
AT kunzelmannkarl tmem16fanoctamin6inferroptoticcelldeath